References
- Marr KA, Patterson T, Denning D. Aspergillosis. Pathogenesis, clinical manifestations, and therapy. Infect Dis Clin North Am 2002; 6: 875–94
- Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000; 79: 250–60
- Meersseman W, Vandecasteele SJ, Wilmer A, Verbeken E, Peetermans WE, Van WE. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med 2004; 170: 621–5
- Meeker DP, Gephardt GN, Cordasco EM, Jr, Wiedemann HP. Hypersensitivity pneumonitis versus invasive pulmonary aspergillosis: 2 cases with unusual pathological findings and review of the literature. Am Rev Respir Dis 1991; 143: 431–6
- Batard E, Renaudin K, Morin O, Desjars P, Germaud P. Fatal acute granulomatous pulmonary aspergillosis in a healthy subject after inhalation of vegetal dust. Eur J Clin Microbiol Infect Dis 2003; 22: 357–9
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–803
- Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37 (Suppl 3): S265–80
- Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: state of the art. Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003; 37 (Suppl 3): S225–64
- Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002; 110: 685–92
- Zuk JA, King D, Zakhour HD, Delaney JC. Locally invasive pulmonary aspergillosis occurring in a gardener: an occupational hazard?. Thorax 1989; 44: 678–9
- Dutkiewicz J, Krysinska-Traczyk E, Prazmo Z, Skorska C, Sitkowska J. Exposure to airborne microorganisms in Polish sawmills. Ann Agric Environ Med 2001; 8: 71–80
- Clancy CJ, Nguyen MH. Acute community-acquired pneumonia due to Aspergillus in presumably immunocompetent hosts: clues for recognition of a rare but fatal disease. Chest 1998; 114: 629–34
- Yoshimoto A, Ichikawa Y, Waseda Y, Yasui M, Fujimura M, Hebisawa A, Nakao S. Chronic hypersensitivity pneumonitis caused by Aspergillus complicated with pulmonary aspergilloma. Intern Med 2004; 43: 982–5
- Maertens J, Verhaegen J, Demuynck H, Brock P, Verhoef G, Vandenberghe P, et al. Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for haematological patients at risk for invasive aspergillosis. J Clin Microbiol 1999; 37: 3223–8
- Herbrecht R, Letscher-Bru V, Oprea C, Lioure B, Waller J, Campos F, et al. Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. J Clin Oncol 2002; 20: 1898–1906
- Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653–6
- Kan VL, Bennett JE. Lectin-like attachment sites on murine pulmonary alveolar macrophages bind Aspergillus fumigatus conidia. J Infect Dis 1988; 158: 407–14
- Schaffner A. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest 1985; 76: 1755–64
- Ng TT, Robson GD, Denning DW. Hydrocortisone-enhanced growth of Aspergillus spp.: implications for pathogenesis. Microbiology 1994; 140: 2475–9
- Balloy V, Huerre M, Latge JP, Chignard M. Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 494–503
- Cornet M, Mallat H, Somme D, Guerot E, Kac G, Mainardi JL, et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients: a 2-case report. Clin Microbiol Infect 2003; 9: 1224–7